Program Overview
Please read the following program information before accessing the presentations using links located at the bottom of this page
Release Date: March 1, 2009 Expiration Date: February 28, 2010
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program provides 3 hours (0.3 CEUs) of continuing education credit (program number 204-000-08-481-H01P).
Methods and Format
This is an online activity consisting of audio and slides for four presentations, a post-test, and an activity evaluation tool. Participants must view all presentations, take the activity post-test, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time to complete this activity is 3 hours. This activity is provided free of charge.
Target Audience
This continuing education activity was planned to meet the needs of pharmacists in a variety of practice settings, including large and small health systems, managed-care organizations, long-term care facilities, ambulatory clinics, outpatient pharmacies, and academia. This activity would be particularly beneficial for pharmacists, including clinicians, managers, and educators, who are interested in learning about current trends and guidelines regarding the supportive care of patients with or at risk for cancer-related complications.
Activity Content
Click here to view an overview of the activity content.Learning Objectives
After attending this application-based activity, participants should be able to do the following for each of the four cancer-related complications discussed in this activity (febrile neutropenia, tumor lysis syndrome, thrombosis of cancer, and chemotherapy-induced nausea and vomiting):
- Explain the rationale for a proactive approach to risk assessment and prevention.
- Given patient case information, identify the patient’s risk for developing the complication.
- Given patient case information, describe treatment options for a patient at high risk for developing the complication and for a patient with the complication.
Faculty
Michael J. Berger, Pharm.D., BCOP
Program Chair
Specialty Practice Pharmacist, Outpatient Oncology
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
The Ohio State University
Columbus, Ohio
Michael Vozniak, Pharm.D., BCOP
Hematology/Oncology Clinical Pharmacy Specialist
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Dawn Goetz, Pharm.D., BCOP
Clinical Pharmacy Specialist, Medical Oncology
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida
David Frame, Pharm.D.
Assistant Professor
University of Michigan College of Pharmacy
Clinical Hematology/Oncology Specialist
University of Michigan Health System
Ann Arbor, Michigan
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of program content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.
The faculty and planners report the following relationships:Michael J. Berger, Pharm.D., BCOP, declares that he has no relationships pertinent to this activity.
Michael Vozniak, Pharm.D., BCOP, declares that he has no relationships pertinent to this activity.
Dawn Goetz, Pharm.D., BCOP, declares that she has no relationships pertinent to this activity.
David Frame, Pharm.D., declares the following relationship: consultant for Merck.
Lorrie LeClair, Pharm.D., declares that she has no relationships pertinent to this activity.
This activity is supported by educational grants from Eisai, Inc. and sanofi-aventis U.S. The supported activities are also sponsored by an educational donation provided by Amgen.
Launch Presentation
Preventing and Treating Febrile Neutropenia: A Case Study (30 minutes)
Preventing and Treating Tumor Lysis Syndrome: A Case Study (30 minutes) 
Preventing and Treating Thrombosis of Cancer: A Case Study (30 minutes)
Dawn Goetz, Pharm.D., BCOP
Preventing and Treating Chemotherapy-Induced Nausea and Vomiting: A Case Study (30 minutes) Download Post-Test
Click here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Learning Center and complete the test online.
